Piedmont Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-27,667
| Closed | -$6.58M | – | 679 |
|
|
2020
Q1 | $6.58M | Buy |
27,667
+3,696
| +15% | +$879K | 0.26% | 89 |
|
|
2019
Q4 | $5.25M | Buy |
23,971
+1,020
| +4% | +$223K | 0.18% | 129 |
|
|
2019
Q3 | $3.89M | Buy |
22,951
+329
| +1% | +$55.7K | 0.15% | 147 |
|
|
2019
Q2 | $4.15M | Buy |
22,622
+22
| +0.1% | +$4.03K | 0.17% | 139 |
|
|
2019
Q1 | $4.16M | Buy |
22,600
+349
| +2% | +$64.2K | 0.17% | 137 |
|
|
2018
Q4 | $3.69M | Buy |
22,251
+1,213
| +6% | +$201K | 0.18% | 125 |
|
|
2018
Q3 | $4.06M | Buy |
21,038
+10,061
| +92% | +$1.94M | 0.17% | 128 |
|
|
2018
Q2 | $1.87M | Sell |
10,977
-26,781
| -71% | -$4.55M | 0.09% | 227 |
|
|
2018
Q1 | $6.15M | Sell |
37,758
-16,347
| -30% | -$2.66M | 0.16% | 159 |
|
|
2017
Q4 | $8.11M | Sell |
54,105
-177
| -0.3% | -$26.5K | 0.16% | 165 |
|
|
2017
Q3 | $8.25M | Buy |
54,282
+1,151
| +2% | +$175K | 0.18% | 155 |
|
|
2017
Q2 | $6.85M | Buy |
53,131
+914
| +2% | +$118K | 0.15% | 176 |
|
|
2017
Q1 | $5.71M | Buy |
52,217
+454
| +0.9% | +$49.6K | 0.12% | 201 |
|
|
2016
Q4 | $3.81M | Buy |
51,763
+1,118
| +2% | +$82.4K | 0.08% | 227 |
|
|
2016
Q3 | $4.42M | Sell |
50,645
-5,233
| -9% | -$456K | 0.1% | 213 |
|
|
2016
Q2 | $4.81M | Buy |
55,878
+1,215
| +2% | +$105K | 0.1% | 205 |
|
|
2016
Q1 | $4.35M | Buy |
54,663
+840
| +2% | +$66.8K | 0.09% | 197 |
|
|
2015
Q4 | $6.77M | Buy |
53,823
+476
| +0.9% | +$59.9K | 0.14% | 155 |
|
|
2015
Q3 | $5.56M | Buy |
53,347
+427
| +0.8% | +$44.5K | 0.13% | 177 |
|
|
2015
Q2 | $6.53M | Buy |
+52,920
| New | +$6.53M | 0.14% | 172 |
|